$MIST
Milestone Pharmaceuticals Inc. Common Shares
XNAS•Health Care•Pharmaceutical Preparations
$0.763
▼-0.14%-$0.001
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateMilestone Pharmaceuticals Inc. Common Shares
XNAS•Health Care•Pharmaceutical Preparations
Why is MIST down today? It is at $0.763 (-0.14%), and our scanner flagged it 48 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment MIST spikes, and full due diligence on MIST — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $MIST 48 times in the last 30 days. Create a free account to track $MIST, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on MIST from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for MIST today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystMilestone Pharmaceuticals Announces NMPA ApprovalReported Approval Triggers $2.0 Million Payment to MilestoneReported approval of etripamil outside the United States and triggers a $2.0 million milestone payment to Milestone Pharmaceuticals. EverestReported Kong, Macau and Taiwan). Under the License Agreement with Everest, Milestone is also eligible to receive up to $98.0 million in commercial, from the latest SEC filing. Read it →Across every filing on file, supply equal to 561% of the tradeable float is in play - 561% more can still be issued.
Shelf sizes are dollars, so shares are estimated at today's price.
Active shelf on file — the company can issue new shares on demand (valid ~3 years)
About $300.0M in size
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Oliveto Joseph Officer | Sold (automatic/other) | -37K 0.03% of company | sold 7.6% | 446K | $82K at $2.26 | Apr 16, 26 |
Muller Lorenz Officer | Sold (automatic/other) | -11K | sold 5.2% | 205K | $22K at $1.93 | Jan 26, 26 |
Muller Lorenz Officer | Other | 20K 0.02% of company | added 10% | 217K | n/a | Jan 26, 26 |
Oliveto Joseph Officer | Sold (automatic/other) | -35K 0.03% of company | sold 6.7% | 483K | $67K at $1.93 | Jan 26, 26 |
Oliveto Joseph Officer | Other | 67K 0.05% of company | added 15% | 517K | n/a | Jan 26, 26 |
Bharucha David Officer | Sold (automatic/other) | -12K | sold 9.8% | 113K | $24K at $1.93 | Jan 26, 26 |
Bharucha David Officer | Other | 20K 0.02% of company | added 19% | 125K | n/a | Jan 26, 26 |
Nelson Jeffrey Edward Officer | Sold (automatic/other) | -12K | sold 20% | 50K | $24K at $1.93 | Jan 26, 26 |
Nelson Jeffrey Edward Officer | Other | 20K 0.02% of company | added 48% | 62K | n/a | Jan 26, 26 |
Hasija Amit Officer | Sold (automatic/other) | -12K | sold 11% | 100K | $24K at $1.93 | Jan 26, 26 |
Hasija Amit Officer | Other | 20K 0.02% of company | added 22% | 112K | n/a | Jan 26, 26 |
Oliveto Joseph Officer | Sold (automatic/other) | -43K 0.03% of company | sold 12% | 304K | $97K at $2.25 | Jan 8, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on MIST from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for MIST today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
MIST last traded at $0.763, down 0.14% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Milestone Pharmaceuticals Inc. Common Shares (MIST) is next expected to report earnings on Wednesday, November 11, 2026, about 35 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The MIST Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged MIST 48 times in the last 30 days.
MIST (Milestone Pharmaceuticals Inc. Common Shares) trades on XNAS, with a market cap of about $94M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge MIST for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$MIST discussion
Sign in to ask a question or join the discussion.